Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 - Wikidata - awgldk - TriplyDB

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

http://www.wikidata.org/entity/Q29619511

about

HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response Structural mechanism of trimeric HIV-1 envelope glycoprotein activation bNAber: database of broadly neutralizing HIV antibodies Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk Increasing the potency and breadth of an HIV antibody by using structure-based rational design Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals Immunoregulatory functions of immune complexes in vaccine and therapy The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection Immune correlates of vaccine protection against HIV-1 acquisition The HIV glycan shield as a target for broadly neutralizing antibodies Recent strategies targeting HIV glycans in vaccine design Advances in structure-based vaccine design Structural insights on the role of antibodies in HIV-1 vaccine and therapy A Blueprint for HIV Vaccine Discovery Cells and cell lysates: a direct approach for engineering antibodies against membrane proteins using yeast surface display A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes Antibody responses to envelope glycoproteins in HIV-1 infection HIV-1 neutralizing antibodies: understanding nature's pathways The Antibody Response against HIV-1 Vaccine applications of flow cytometry HIV-1 envelope glycoprotein structure Antibodies in HIV-1 vaccine development and therapy HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design Virological features associated with the development of broadly neutralizing antibodies to HIV-1 HIV broadly neutralizing antibody targets Catching HIV 'in the act' with 3D electron microscopy Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1 Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity

P2860

Q21090490-20138920-9C02-4DCF-819A-F59FCF6BC19E Q21131394-ECE0A586-F038-4B9D-8379-2ED49902528C Q24567758-47564D39-5B9D-4D73-A11B-CDC0F39A58F7 Q24598653-9BB0DA84-0530-41ED-9D4A-21D882A7305C Q24631510-20F0DEFF-C46C-49C6-9C6E-2B08A378C240 Q24635002-E506B055-AF78-41F9-82BB-6C35C650B6F6 Q26738396-8FFC686F-661C-41E8-83D0-7E41D1C0AF4B Q26771289-A273316D-384C-4DB5-82D2-1142126C0AFF Q26775082-7E72FB72-FF3F-4CF1-95D5-3C943585A9FB Q26778573-3C181067-3870-43DA-A68F-671118C4309C Q26786540-0E1046A2-7E33-4F15-B12D-631D9F0FFB1C Q26823603-64AFB8B1-5B18-4928-B9B2-D768CC5928DA Q26824545-2817B8B2-9437-4C9A-9D30-850D0A4B6F5F Q26829461-15E16161-10FB-42EC-A870-22E4C789AE5D Q26829865-33305EF0-AC3E-4E39-A2FD-8ABEA2CE8EB7 Q26849777-4B41DDF6-B73C-489A-9B27-753794F6EB25 Q26860116-8110D6B8-A80A-40F1-A2B2-D77F3E3A3E24 Q26991572-4A8E8001-F7EB-4A6D-98AE-8E2D43C0D441 Q27000480-3F32C964-5C09-4521-94E3-BF3D6F3FC6F2 Q27000889-0A026D96-83AE-4EB1-A966-139859B5332E Q27004341-4785BC99-89C9-455F-91EB-5C9B12932183 Q27011248-EDCE1FA2-55D2-4409-B13D-33CEC6D5B36A Q27011574-6632A07A-1E09-43A1-96BB-B558BFF051FE Q27022055-D7112A3E-A5FD-4B61-8A90-D59AF04B2354 Q27025177-553B6762-DE29-471C-AF6F-0E4B9C5EB11E Q27026662-F0BC59B2-0863-4AD7-89EC-FB549F0E43B9 Q27026806-30EAD6FD-3955-4F57-85D3-9821E707D04D Q27304735-E770E3EE-3873-4B76-97A2-718EE1F20566 Q27319450-A22A1E7F-3CD1-48AE-B5EB-EF7FD7139C12 Q27322403-A80B430B-EC57-4F66-B0A4-BF9680873642 Q27322437-23436856-71AF-45FF-9224-0986750AF2A2 Q27324184-63357F95-A71C-4921-B527-860F0CCB022A Q27643993-70ACA138-789D-420D-8E24-AEE2B89236DF Q27644383-DBDA66AC-3097-49BC-8BB0-BB8D55411D07 Q27644415-3B30DA8F-F0FC-45E4-9AD7-9ADBB5FDF607 Q27644501-B67B4704-7C5A-41C0-AC21-0F41CED5782A Q27644515-36E10219-5EFD-42AB-8650-73FC666D4054 Q27644634-580BF8EF-34A6-48C3-B69B-6F37A2093590 Q27644646-EB9F7F24-A52C-4776-B83C-D1C20A3822A2 Q27654848-E9050F45-4A6F-4276-AA3A-8DF38C63A54B

P2860

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

http://www.wikidata.org/entity/Q29619511

description

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Science

@fr

artículu científicu espublizáu en 2010

@ast

im August 2010 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 13 August 2010)

@en

wetenschappelijk artikel (gepubliceerd op 2010/08/13)

@nl

наукова стаття, опублікована в серпні 2010

@uk

مقالة علمية (نشرت في 13-8-2010)

@ar

name

Rational design of envelope id ...... monoclonal antibodies to HIV-1

@ast

Rational design of envelope id ...... monoclonal antibodies to HIV-1

@en

type

label

Rational design of envelope id ...... monoclonal antibodies to HIV-1

@ast

Rational design of envelope id ...... monoclonal antibodies to HIV-1

@en

prefLabel

Rational design of envelope id ...... monoclonal antibodies to HIV-1

@ast

Rational design of envelope id ...... monoclonal antibodies to HIV-1

@en

P1433

Q29619511-79B799A7-F5BE-4218-9DFA-E6781BCFDBEF

P1476

Q29619511-AE1CFFE4-A0AE-4ABF-A5D8-6B123C34B704

P2093

Q29619511-00BAC724-4C2B-49D4-88C9-52879F292F9A

Q29619511-11FE71D4-B697-42C2-B6DB-8CB8962AD8DF

Q29619511-15466704-031B-4857-B816-1CE3EA01E90E

Q29619511-161ADD48-41E9-49BB-8EFE-E61C4A3D4C1F

Q29619511-19EBF693-5285-488D-AB81-0F735091C2DB

Q29619511-2512D175-B048-48A6-BA14-2B9D86C62342

Q29619511-3C0047D6-CF4B-463E-8846-FD6FDD47DB07

Q29619511-464AAB39-E379-45A0-B685-A24CB6DBE219

Q29619511-4981A079-E206-4DC2-B07A-F0E5463C0114

Q29619511-74E8DED2-98B3-477E-AD38-FEB1B1A6BB1C

P2860

Q29619511-034C8A3C-7193-40A9-AF77-7DC7307E4121

Q29619511-09FFD9B7-5633-4B7B-ADBA-D211097691D4

Q29619511-0A34C9AD-963A-4B58-896C-C0C8D9F92132

Q29619511-2F22AE89-98E5-444A-B871-06D51D17DBDA

Q29619511-3A5E0B4A-8BBE-4E20-8CAC-B1EFFEF99F29

Q29619511-3F3AB04F-9107-4D4A-8873-7BD9B3B3C631

Q29619511-415870E3-815A-4E56-A695-01DA7EF35E95

Q29619511-4D0BA5BC-E0C1-4CA2-BA0A-F5CAEF74A097

Q29619511-581AFE45-B2C8-47A1-A040-8C261263506B

Q29619511-5DA7EC07-BC14-4E86-B67D-BF338E4CBBA8

P304

Q29619511-1057EBCD-D0B6-4EBE-AB69-7BA6263C3B95

P31

Q29619511-509F0F45-7D96-47C2-BA33-A3225A2C2458

P3181

Q29619511-4FC759B8-0F65-41AB-8662-54F02823ABCA

P356

Q29619511-7DCB8546-2C2B-4D97-9D0D-04F1B5C9043F

P407

Q29619511-18BCA673-86D3-4735-89E3-79147ADFA41F

P433

Q29619511-C8A9C293-DFF8-4DC8-9506-723C75EB9C7C

P478

Q29619511-D23CAEBF-57A0-4B2C-9C37-BF6A102B337C

P50

Q29619511-15D1AD4E-092C-47E7-81DF-F40ED26B06C4

Q29619511-449EF62E-28B0-4791-A034-69A4C7FFD803

Q29619511-A011FBFA-594B-4AC0-ABBF-4F537C5A6286

P5008

Q29619511-419EFF59-9D90-400F-8388-89AE33D15541

P577

Q29619511-E9A3EA38-2430-484E-877D-841515879F17

P5875

Q29619511-D7B5B29A-5ADD-4EDF-BF73-8B0E82F460D4

P698

Q29619511-B878E17B-0614-452D-B47B-5F19DE81852A

P921

Q29619511-0E807262-27DB-4708-B498-D21F7EBFD966

Q29619511-A548935C-D84A-457F-B1C8-06B0570CEE76

P932

Q29619511-02AF4032-4413-45C9-92CD-FB0C9F0AD39C

P3181

P356

SCIENCE.1187659

P1433

P1476

Rational design of envelope id ...... monoclonal antibodies to HIV-1

@en

P2093

Carl-Magnus Hogerkorp

http://www.w3.org/2001/XMLSchema#string

Diane L Wycuff

http://www.w3.org/2001/XMLSchema#string

John R Mascola

http://www.w3.org/2001/XMLSchema#string

Krisha McKee

http://www.w3.org/2001/XMLSchema#string

Lan Wu

http://www.w3.org/2001/XMLSchema#string

Ling Xu

http://www.w3.org/2001/XMLSchema#string

Mario Roederer

http://www.w3.org/2001/XMLSchema#string

Mark Connors

http://www.w3.org/2001/XMLSchema#string

Mark K Louder

http://www.w3.org/2001/XMLSchema#string

Martha Nason

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

The antigenic structure of the HIV gp120 envelope glycoprotein

GP120: target for neutralizing HIV-1 antibodies

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

Structure of an unliganded simian immunodeficiency virus gp120 core

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

P304

856-861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

190513

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1187659

http://www.w3.org/2001/XMLSchema#string

P407

P433

5993

http://www.w3.org/2001/XMLSchema#string

P478

329

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113775

http://www.w3.org/2001/XMLSchema#string

P698

20616233

http://www.w3.org/2001/XMLSchema#string

P921

P932

2965066

http://www.w3.org/2001/XMLSchema#string